Table 1 Characteristics and anthropometric measurements of the study subjects
Pre (0w) | Post treatment (12w) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Control | SGLT2i | CRIC | Control | %â–³Control | SGLT2i | %â–³SGLT2i | CRIC | %â–³CRIC | |
Duration of diabetes (years) | 0.8 ± 0.6 | 4.4 ± 2.6 | 4.5 ± 2.1 | – | – | – | – | – | – |
Age (years) | 50.4 ± 14.0 | 53.8 ± 15.2 | 56.9 ± 15.6 | – | – | – | – | – | – |
Sex (Male/Female) | 4/4 | 6/2 | 4/3 | – | – | – | – | – | – |
Height (cm) | 165.5 ± 12.4 | 165.2 ± 9.5 | 160.9 ± 7.8 | – | – | – | – | – | – |
Weight (kg) | 75.9 ± 16.6 | 72.7 ± 18.7 | 65.4 ± 9.4 | 71.7 ± 15.8 | -2.2 ± 6.8 | 70.2 ± 16.5 | 1.1 ± 5.0 | 66.8 ± 9.8 | 2.4 ± 6.2 |
BMI (kg/m2) | 27.7 ± 5.1 | 26.3 ± 5.1 | 25.2 ± 3.0 | 26.2 ± 4.1 | -2.2 ± 6.8 | 25.9 ± 4.4 | 1.1 ± 5.0 | 25.8 ± 2.8 | 2.4 ± 6.2 |
Total body muscle mass (kg) | 49.2 ± 12.3 | 51.1 ± 13.1 | 42.8 ± 6.4 | 50.5 ± 15.6 | 2.7 ± 6.2 | 50.3 ± 12.7 | 3.0 ± 2.0 | 46.6 ± 8.1 | 8.6 ± 5.8 * ** |
Total body fat mass (kg) | 23.5 ± 12.0 | 18.4 ± 6.5 | 19.9 ± 5.5 | 17.9 ± 10.1 | -15.5 ± 25.2 | 16.8 ± 4.7 | -2.1 ± 20.3 | 17.3 ± 6.3 | -12.6 ± 16.7 |